Richards, Jackson R.
Shin, Donghan
Pryor, Rob
Sorensen, Lise K.
Sun, Zhonglou
So, Won Mi
Park, Garam
Wolff, Roger
Truong, Amanda
McMahon, Martin http://orcid.org/0000-0003-2812-1042
Grossmann, Allie H.
Harbour, J. William http://orcid.org/0000-0002-1104-9809
Zhu, Weiquan
Odelberg, Shannon J. http://orcid.org/0000-0001-5935-0468
Yoo, Jae Hyuk http://orcid.org/0000-0001-9359-8109
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R00CA230312, F30CA217184, F30CA235964, R01CA202778)
U.S. Department of Defense (ME190288)
Melanoma Research Foundation (51005681)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P20GM121316)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 28 October 2022
Revised: 12 July 2023
Accepted: 19 July 2023
First Online: 27 July 2023
Change Date: 8 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41388-023-02828-x
Competing interests
: JWH is the inventor of intellectual property related to prognostic testing in uveal melanoma. He is a paid consultant for Castle Biosciences, licensee of this intellectual property, and he receives royalties from its commercialization.